Lam Research Corporation - 10-Q Summary
Business Context and Reporting Period
Lam Research Corporation is a leading supplier of thin film selective removal equipment for semiconductor manufacturing. This report covers the quarterly period ended December 30, 2001, and the six months ended on that date. The company operates in a cyclical industry currently experiencing a severe downturn in demand, leading to reduced capital expenditures by semiconductor manufacturers.
Key Financial Metrics
| Metric | Three Months Ended Dec 30, 2001 | Six Months Ended Dec 30, 2001 |
|---|---|---|
| Total Revenue | $259.2 million | $598.8 million |
| Gross Margin | $26.6 million (10.3%) | $144.8 million (24.2%) |
| Operating Loss | ($100.4 million) | ($90.1 million) |
| Net Loss | ($51.7 million) | ($60.6 million) |
| Net Loss Per Share (Diluted) | ($0.41) | ($0.48) |
| Cash & Equivalents | $100.9 million | $100.9 million (Balance Sheet) |
| Short-term Investments | $779.3 million | $779.3 million (Balance Sheet) |
| Total Debt (Current + Long-term) | $670.3 million | $670.3 million (Balance Sheet) |
Note: Net loss figures exclude the cumulative effect of accounting changes recorded in the prior fiscal year.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 32.5% for the quarter and 13.1% for the six-month period compared to the prior year, reflecting the contraction in the semiconductor equipment market.
- Margin Compression: Gross margin percentage dropped significantly to 10.3% (quarter) and 24.2% (six months) from 44.3% and 43.9% in the prior year. This was driven by excess capacity, inventory write-downs, and one-time charges.
- Restructuring Charges: The company recorded $33.8 million in restructuring charges for the quarter (part of a $71.0 million total for the six months) related to three separate plans (June, September, and December 2001) to reduce headcount and consolidate facilities.
- Patent Litigation Settlement: A special charge of $38.8 million was recorded in the quarter to settle patent litigation with Varian Semiconductor Equipment Associates, Inc.
- Impairment Charges: An additional $9.5 million impairment charge was taken for laboratory and demonstration equipment due to technological shifts toward copper and 300mm applications.
- Derivative Gains: A non-taxable gain of $18.9 million was recognized in "Other Income" due to the increase in the fair value of equity derivative contracts indexed to the company's stock.
Guidance, Outlook, and Risks
- Outlook: Management expects lower revenues in the next two quarters due to reduced customer capital expenditures and delayed equipment deliveries. Gross margins are expected to remain below 35% due to under-utilization of production resources.
- Cost Reduction: The company is implementing cost containment programs, including outsourcing manufacturing functions, to offset unabsorbed costs.
- Liquidity: As of December 30, 2001, the company held approximately $941 million in cash, cash equivalents, and short-term investments. Management believes this is sufficient to support operations and debt obligations for at least the next 12 months.
- Key Risks:
- High volatility in the semiconductor industry and unpredictable quarterly results.
- Revenue recognition delays due to customer acceptance periods (SAB 101).
- Risks associated with rapid technological changes rendering current inventory obsolete.
- Dependence on a limited number of key suppliers and customers.
Investor Verification Checklist
- Restructuring Execution: Verify the actual cash outflow and timeline for the $33.8 million December 2001 restructuring plan and the remaining reserves from prior plans.
- Inventory Valuation: Assess the adequacy of inventory reserves given the rapid shift to copper and 300mm technologies and the $24.1 million write-down already taken.
- Debt Maturity: Review the terms of the $310 million 5% Convertible Notes maturing in September 2002 and the company's ability to refinance or convert them.
- Derivative Exposure: Monitor the fair value of equity derivatives (put/call options), which fluctuate with stock price and impact "Other Income" significantly.
- Revenue Recognition: Confirm the status of deferred revenue ($151 million) and the timeline for customer acceptances to recognize future revenue.